Research Paper Volume 14, Issue 19 pp 7986—8000

Figure 1. Expression of FHL2 in normal population and lung cancer patients and its relationship with clinicopathological parameters. (A) The expression difference of FHL2 between normal population and lung cancer patients. (B, C) Expression of FHL2 in different histological types and stages. (D–F) The relationship between FHL2 expression and T classification, N classification, and M classification. (G–L) The relationship between FHL2 expression and age, gender, vital status, radiotherapy, residual tumor, and recurrent tumors. ^*P < 0.05; ^**P < 0.01.